Clinical Lateral Flow Assay Markets in Indonesia: Trends & Forecasts

  • ID: 3771228
  • Report
  • Region: Indonesia
  • 140 Pages
  • AcuBiz Consulting Sdn Bhd
1 of 5
Clinical LFIA Rapid Tests Market Size by Unit Shipments is Expected to Grow at a CAGR of 13% Between 2016 and 2021

FEATURED COMPANIES

  • Alere Inc.
  • bioMerieux SA
  • CTK Biotech, Inc
  • InTec Products Inc.
  • PT Oncoprobe Utama
  • PT Rajawali Nusindo
  • MORE
The success of home-based pregnancy tests in lateral flow format has been instrumental in the growth of lateral flow immunoassay (LFIA) as a platform accepted across widely different application segments. Ease of use combined with accuracy in majority of situations is driving the clinical use of LFIA tests for the diagnosis of various infectious diseases, cancer, cardiac disease, and drug of abuse tests.

While developed markets such as North America and Europe have the highest market demand for these products, the Asia Pacific region is the fastest growing market for these tests. The manufacturers are responding to the growing market demand by developing tests for several tropical infectious diseases including malaria, dengue, and typhoid. Apart from large markets such as China and India, many small countries are also indicating strong demand for these products. For instance, several Southeast Asian countries can be categorized under emerging markets for these products. One such key market in the region is Indonesia, mainly due to its large population of over 200 million and high prevalence of several infectious diseases.

Indonesia’s healthcare market is on the verge of rapid growth at this point, as the government is taking steps to improve access to quality healthcare for its population by implementing universal health coverage (UHC) for 100% of its population by 2019. In addition to this, regulations promoting e-commerce as a measure to tackle corruption practices in the public sector is also changing the face of healthcare system in Indonesia.

This report analyses Indonesian demand for clinical LFIA rapid tests and forecasts its growth. The market size by unit shipments for these products is expected to grow at a CAGR of 13% between 2016 and 2021. However, revenue growth is expected to grow at a lower rate, at around 10.2%. The increasing significance of community healthcare centers in Indonesia as primary healthcare providers is one of the major factors driving this growth. However, e-commerce regulations are expected to impact revenues and profit margins from these products.

This report assesses the regulatory landscape of the healthcare sector with a particular focus on the criteria important for foreign companies interested in this market. It also assesses the prevalence of various diseases in each provinces of Indonesia, which is critical for companies to develop strategies based on the tests that will have highest demand. Finally, the report analyses key brands available in Indonesia, its manufacturers, and distributors.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Alere Inc.
  • bioMerieux SA
  • CTK Biotech, Inc
  • InTec Products Inc.
  • PT Oncoprobe Utama
  • PT Rajawali Nusindo
  • MORE
Executive Summary

Introduction
- Study Goal and Outline
- Rational for this Study
- Targeted Audience
- Market Definition and Scope
- Information Sources
- Methodology
- Disclaimer
- Background of the Study

Chapter 1: Market Overview
- General Characteristics of the Indonesian Market
- Overview of Indonesia's Healthcare Market
- Table 1: Key Market Trends and Drivers Influencing Indonesia’s Healthcare Sector
- Figure 1: Indonesia - Healthcare Delivery System
- Table 2: Number of Hospitals in Indonesia by Ownership, 2016
- Figure 2: Hospital Industry Landscape, 2017
- Upcoming Investments in Private Healthcare Segment in Indonesia
- Table 3: Distribution of Community Healthcare Centers (CHCs) in Indonesia
- Table 4: Distribution of Medical Device Distributors in Indonesia
- Indonesia’s Healthcare Sector: Market Challenges
- Table 5: Key Market Challenges of Indonesia’s Healthcare Sector

Chapter 2: Regulatory Trends & Insights Relevant for IVD Sector
- Processes for Distribution License, Company & Product Registrations
- Table 6: Licenses Required for IVD Distribution
- Market Transition to E-Catalogue and Related Regulations
- Regulations for Foreign Direct Investments
- Table 7: Contact Details of BKPM Offices Worldwide for Investing in Indonesia
- The Impact of Negative List on FDI
- Setting up a Company in Indonesia: Tips for Foreign Investors
- Options for an IVD Company to Enter Indonesian Market
- Table 8: Options for a Foreign IVD Company to Enter Indonesian Market
- Business Strategies Adopted by MNCs: Case Studies
- Important factors to consider while choosing IVD Distributor in Indonesia

Chapter 3: Industry Structure
- Indonesian Market Landscape for LFIA-Based Rapid Tests
- Why LFIA-Based Rapid Tests?
- Assessment of End-Users
- Demand Trends in Indonesian Red Cross Segment
- Demand Trends in Government sector
- Demand Trends in Private sector
- Figure 3: Market Segmentation by End-User Categories
- Supplier Trends: Leading Brands in Indonesia
- Table 9: Popular LFIA-based Rapid Test Brands and their Distributors in Indonesia
- Supplier Trends: Assessment of Rapid Test Distributors
- Common Infectious Diseases and Demand for Rapid Tests for Diagnosing them in Indonesia
- Market Size and Market Forecast (2016-2021)
- Figure 4: Market Forecast for Clinical LFIA-Based Rapid Tests, By Revenues (2016-2021)

Chapter 4: Statistics of Highly Prevalent Infectious Diseases in Indonesia
- Table 10: Pulmonary Tuberculosis Cases by Province - 2013
- Table 11: HIV Cases BY Province, 2013
- Table 12: Malaria Cases and Prevalence in Indonesia by Province - 2014
- Table 13: Dengue Hemorrhagic Fever (DHF) Cases by Province - 2013
- Table 14: Filariasis Cases by Province - 2012-2014
- Table 15: Leptospirosis Cases by Province - 2013
- Table 16: Typhoid Prevalence in Indonesia

Chapter 5: Company Profiles
- Profiles of Manufacturers of Top LFIA-Based Rapid Test Brands in Indonesia
- Alere Inc.
- CTK Biotech, Inc
- PT Fokus Diagnostic Indonesia
- PT Oncoprobe Utama
- Figure 4: Distribution Coverage of PT Oncoprobe Utama
- InTec Products Inc.
- Blue Cross Bio-Medical (Beijing) Co., Ltd.
- bioMerieux SA
- Table 17: bioMerieux Rapid Test Portfolio
- Nova Century Scientific, Inc
- Profiles of Rapid Test Distributors in Indonesia
- PT Anugrah Argon Medika (AAM)
- PT Enseval Putera Megatrading (EPM)
- PT Enseval Medika Prima (EMP)
- Figure 5: Enseval Group Structure
- Figure 6: Logistics Coverage of EPM
- PT Rajawali Nusindo
- Figure 7: Logistics Coverage of Rajawali Nusindo
- PT Primarindo Multi Alkestama
- Figure 8: Market Coverage of Primarindo
- PT Pacific Biotekindo Intralab
- PT Syifana Berkah Indonesia
- PT Sekarguna Medika

Glossary
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Alere Inc.
- bioMerieux SA
- Blue Cross Bio-Medical (Beijing) Co., Ltd.
- CTK Biotech, Inc
- InTec Products Inc.
- Nova Century Scientific, Inc
- PT Anugrah Argon Medika (AAM)
- PT Enseval Medika Prima (EMP)
- PT Enseval Putera Megatrading (EPM)
- PT Fokus Diagnostic Indonesia
- PT Oncoprobe Utama
- PT Pacific Biotekindo Intralab
- PT Primarindo Multi Alkestama
- PT Rajawali Nusindo
- PT Sekarguna Medika
- PT Syifana Berkah Indonesia
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll